Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06768450 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Online Meditation for Mild Cognitive Impairment and Mild Dementia

StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 16, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
  2. Eligibility criteria expanded, about 10 words
    • Secondary endpoints revised (3)
    • Study description shortened, about 3 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
King's College London
136 trials monitored
See 3 trials at risk
Dementia
1,978 trials monitored
See 106 trials at risk
The study will look at whether online mindfulness meditation (OMM) is easy for older adults with mild cognitive impairment (MCI) and mild dementia to use. It will also see how OMM affects their mood, sleep, and quality of life. The investigators will recruit 32 participants, divided into 4 groups of 8 people each. Participants will: * Attend an online mindfulness meditation class once a week for 8 weeks * Practice at home for 20 minutes each day * Keep a simple record of their practice and feelings
Trial Details
NCT Number NCT06768450
Lead Sponsor King's College London
Conditions
(from sponsor)		 Mild Cognitive Impairment (MCI), Dementia
Related terms Cognitive Dysfunction, Dementia
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov